请输入您要查询的百科知识：

　

词条 Stefan Karlsson (professor)
释义

  1. Career

  2. Research

  3. Selected awards and honors

  4. References

{{about|the professor|other people of the same name|Stefan Karlsson (disambiguation){{!}}Stefan Karlsson}}{{BLP sources|date=June 2015}}

Stefan Karlsson, M.D. Ph.D. (born Iceland, 31 May 1950) is a Professor of Molecular Medicine and Gene Therapy at the Lund Stem Cell Center, in the Department of Laboratory Medicine, Lund University, Sweden.[1] He is recognized for significant contributions to the fields of gene therapy and hematopoietic stem cell biology and in 2009 was awarded the Tobias Prize[2] by The Royal Swedish Academy of Sciences.

Career

Dr. Karlsson's field of research is the regulation of hematopoietic stem cells and development of stem cell expansion protocols and gene therapy. He performed postdoctoral studies with Professor Arthur W. Nienhuis (1983-1986) at the National Heart Lung and Blood Institute (NHLBI) at the National Institutes of Health (NIH), Bethesda Maryland, where he received a Fogarty International Research Collaboration Award. He served as Chief of the Molecular and Medical Genetics Section, Developmental and Metabolic Neurology Branch (DMNB), National Institute for Neurological Disorders and Stroke (NINDS), NIH, 1988-1996. In 1995 he was recruited as a full professor to Lund University, Sweden, where he founded the Division of Molecular Medicine and Gene Therapy[3] and has been head of this division for twenty years.[4] He is also a founding and current member of the Lund Stem Cell Center,[5] since 2003, and director of the Hemato-Linné Strategic Research Environment[6] (2006-2016) funded through a 10-year Linneus grant from the Swedish Research Council.[7] Dr. Karlsson also holds a consultant physician position at Skåne University Hospital,[8] Sweden.

Research

Stefan Karlsson is recognized as an important contributor to the field of gene therapy. His early research focused on retroviral vector based gene correction of hematopoietic cells from monogenetic disorders, such as Gaucher’s disease[9] and hemoglobinopathies.[10] The results of these studies led to the first gene therapy clinical trial for the treatment of Gaucher’s disease (1995).[11] He has also developed lentiviral vectors for gene correction of hematopoietic stem cells,[12] and more recently developed preclinical gene therapy models for Gaucher’s disease[13] and Diamond Blackfan anemia.[14] An equal component of his research has been in the field of hematopoietic stem cell biology, where Dr. Karlsson focused on studying the mechanisms of hematopoietic stem cell expansion and maintenance with major contributions to understanding the role of Tgf-beta[15] and more recently Cripto.[16]

Selected awards and honors

  • 1994 Elected member of the American Society for Clinical Investigation (ASCI).
  • 1997 Elected member of the Royal Physiographic Society in Lund.
  • 2006 President International Society for Experimental Hematology (ISEH).[17]
  • 2009 Tobias Prize awarded by The Royal Swedish Academy of Sciences.[18]
  • 2014 Knut and Alice Wallenberg Foundation Excellence in Swedish Research grant.[19]

References

1. ^{{cite web|title=Lund University, Stem Cell Center, Sweden: Stefan Karlsson|url=http://www.med.lu.se/labmedlund/lund_stem_cell_center/research_groups/molecular_medicine}}
2. ^{{cite web|title=Tobias laureates|publisher=The Royal Swedish Academy of Sciences|url=http://www.kva.se/en/Prizes/Tobias-Prize/Laureates/}}
3. ^{{cite web|title=Division of Molecular Medicine and Gene Therapy, Lund University, Sweden|url=http://www.med.lu.se/plain/labmedlund/molecular_medicine_and_gene_therapy}}
4. ^{{cite web|title=Symposium in Honor of Stefan Karlsson: Founder of Division of Molecular Medicine and Gene Therapy|url=http://www.med.lu.se/kalendarium/150515_stefankarlsson/(year)/2015/(month)/5/(day)/15}}
5. ^{{cite web|title=Lund Stem Cell Center|url=http://www.med.lu.se/labmedlund/lund_stem_cell_center}}
6. ^{{cite web|title=Hemato-Linné Strategic Research Environment: Lund University, Sweden|url=http://www.med.lu.se/hemato_linne}}
7. ^{{cite web|title=Swedish Research Counsel: Hemato-Linné Environment coordinated by Stefan Karlsson|url=http://www.vr.se/inenglish/shortcuts/linnaeusenvironments/linnaeusenvironments2006/lunduniversity.4.4b3ca0f810bf51c922780003361.html}}
8. ^{{cite web|title=Skåne University Hospital|url=https://www.skane.se/sv/Webbplatser/Skanes-universitetssjukhus/Skane-University-Hospital/About-Us/}}
9. ^{{cite journal|last1=Fink|first1=JK|last2=Correll|first2=PH|last3=Perry|first3=LK|last4=Brady|first4=RO|last5=Karlsson|first5=S|title=Correction of glucocerebrosidase deficiency after retroviral-mediated gene transfer into hematopoietic progenitor cells from patients with Gaucher disease.|journal=Proceedings of the National Academy of Sciences of the United States of America|date=March 1990|volume=87|issue=6|pages=2334–8|pmid=2315324|doi=10.1073/pnas.87.6.2334|pmc=53681}}
10. ^{{cite journal|last1=Karlsson|first1=S|last2=Bodine|first2=DM|last3=Perry|first3=L|last4=Papayannopoulou|first4=T|last5=Nienhuis|first5=AW|title=Expression of the human beta-globin gene following retroviral-mediated transfer into multipotential hematopoietic progenitors of mice.|journal=Proceedings of the National Academy of Sciences of the United States of America|date=August 1988|volume=85|issue=16|pages=6062–6|pmid=3413076|doi=10.1073/pnas.85.16.6062|pmc=281905}}
11. ^{{cite journal|last1=Dunbar|first1=CE|last2=Kohn|first2=DB|last3=Schiffmann|first3=R|last4=Barton|first4=NW|last5=Nolta|first5=JA|last6=Esplin|first6=JA|last7=Pensiero|first7=M|last8=Long|first8=Z|last9=Lockey|first9=C|last10=Emmons|first10=RV|last11=Csik|first11=S|last12=Leitman|first12=S|last13=Krebs|first13=CB|last14=Carter|first14=C|last15=Brady|first15=RO|last16=Karlsson|first16=S|title=Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation.|journal=Human Gene Therapy|date=20 November 1998|volume=9|issue=17|pages=2629–40|pmid=9853529|doi=10.1089/hum.1998.9.17-2629}}
12. ^{{cite journal|last1=Woods|first1=NB|last2=Fahlman|first2=C|last3=Mikkola|first3=H|last4=Hamaguchi|first4=I|last5=Olsson|first5=K|last6=Zufferey|first6=R|last7=Jacobsen|first7=SE|last8=Trono|first8=D|last9=Karlsson|first9=S|title=Lentiviral gene transfer into primary and secondary NOD/SCID repopulating cells.|journal=Blood|date=1 December 2000|volume=96|issue=12|pages=3725–33|pmid=11090053}}
13. ^{{cite journal|last1=Enquist|first1=IB|last2=Nilsson|first2=E|last3=Ooka|first3=A|last4=Månsson|first4=JE|last5=Olsson|first5=K|last6=Ehinger|first6=M|last7=Brady|first7=RO|last8=Richter|first8=J|last9=Karlsson|first9=S|title=Effective cell and gene therapy in a murine model of Gaucher disease.|journal=Proceedings of the National Academy of Sciences of the United States of America|date=12 September 2006|volume=103|issue=37|pages=13819–24|pmid=16954197|doi=10.1073/pnas.0606016103|pmc=1564262}}
14. ^{{cite journal|last1=Jaako|first1=P|last2=Flygare|first2=J|last3=Olsson|first3=K|last4=Quere|first4=R|last5=Ehinger|first5=M|last6=Henson|first6=A|last7=Ellis|first7=S|last8=Schambach|first8=A|last9=Baum|first9=C|last10=Richter|first10=J|last11=Larsson|first11=J|last12=Bryder|first12=D|last13=Karlsson|first13=S|title=Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia.|journal=Blood|date=1 December 2011|volume=118|issue=23|pages=6087–96|pmid=21989989|doi=10.1182/blood-2011-08-371963}}
15. ^{{cite journal|last1=Kulkarni|first1=AB|last2=Huh|first2=CG|last3=Becker|first3=D|last4=Geiser|first4=A|last5=Lyght|first5=M|last6=Flanders|first6=KC|last7=Roberts|first7=AB|last8=Sporn|first8=MB|last9=Ward|first9=JM|last10=Karlsson|first10=S|title=Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.|journal=Proceedings of the National Academy of Sciences of the United States of America|date=15 January 1993|volume=90|issue=2|pages=770–4|pmid=8421714|doi=10.1073/pnas.90.2.770|pmc=45747}}
16. ^{{cite journal|last1=Miharada|first1=K|last2=Karlsson|first2=G|last3=Rehn|first3=M|last4=Rörby|first4=E|last5=Siva|first5=K|last6=Cammenga|first6=J|last7=Karlsson|first7=S|title=Cripto regulates hematopoietic stem cells as a hypoxic-niche-related factor through cell surface receptor GRP78.|journal=Cell Stem Cell|date=4 October 2011|volume=9|issue=4|pages=330–44|pmid=21982233|doi=10.1016/j.stem.2011.07.016}}
17. ^{{cite web|title=Past Presidents of International Society for Experimental Hematology|url=http://c.ymcdn.com/sites/www.iseh.org/resource/resmgr/2015_Elections/ISEH_Past_Presidents_2014.pdf}}
18. ^{{cite web|title=Tobias Prize Laureates: The Royal Swedish Academy of Sciences|url=http://www.kva.se/en/Prizes/Tobias-Prize/Laureates/}}
19. ^{{cite web|title=Wallenberg Foundation: Excellence in Swedish Research awards 2014|url=https://www.wallenberg.com/kaw/en/sek-12-billion-excellent-swedish-research}}
{{DEFAULTSORT:Karlsson, Stefan}}

7 : 1950 births|Living people|Biotechnologists|Icelandic scientists|Lund University faculty|University of Iceland alumni|Alumni of University College London
随便看

　

开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。

　

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间：2024/11/11 11:55:35